Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Genome Med. 2022 Jul 19;14(1):76. doi: 10.1186/s13073-022-01086-y.
Genome Med. 2022.
PMID: 35854342
Free PMC article.
No abstract available.
Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.
Krimmel-Morrison JD, Ghezelayagh TS, Lian S, Zhang Y, Fredrickson J, Nachmanson D, Baker KT, Radke MR, Hun E, Norquist BM, Emond MJ, Swisher EM, Risques RA.
Krimmel-Morrison JD, et al. Among authors: ghezelayagh ts.
Gynecol Oncol. 2020 Feb;156(2):407-414. doi: 10.1016/j.ygyno.2019.11.124. Epub 2019 Dec 12.
Gynecol Oncol. 2020.
PMID: 31839337
Free PMC article.
Item in Clipboard
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.
Ghezelayagh TS, Pennington KP, Norquist BM, Khasnavis N, Radke MR, Kilgore MR, Garcia RL, Lee M, Katz R, Leslie KK, Risques RA, Swisher EM.
Ghezelayagh TS, et al.
Gynecol Oncol. 2021 Mar;160(3):786-792. doi: 10.1016/j.ygyno.2020.12.007. Epub 2020 Dec 26.
Gynecol Oncol. 2021.
PMID: 33375991
Free PMC article.
Item in Clipboard
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Bartlett TE, Evans I, Jones A, Barrett JE, Haran S, Reisel D, Papaikonomou K, Jones L, Herzog C, Pashayan N, Simões BM, Clarke RB, Evans DG, Ghezelayagh TS, Ponandai-Srinivasan S, Boggavarapu NR, Lalitkumar PG, Howell SJ, Risques RA, Rådestad AF, Dubeau L, Gemzell-Danielsson K, Widschwendter M.
Bartlett TE, et al. Among authors: ghezelayagh ts.
Genome Med. 2022 Jun 15;14(1):64. doi: 10.1186/s13073-022-01063-5.
Genome Med. 2022.
PMID: 35701800
Free PMC article.
Clinical Trial.
Item in Clipboard
Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer.
Ghezelayagh TS, Kohrn BF, Fredrickson J, Manhardt E, Radke MR, Katz R, Gray HJ, Urban RR, Pennington KP, Liao JB, Doll KM, Simons EJ, Burzawa JK, Goff BA, Speiser P, Swisher EM, Norquist BM, Risques RA.
Ghezelayagh TS, et al.
Cancer Res Commun. 2022 Oct;2(10):1282-1292. doi: 10.1158/2767-9764.crc-22-0314. Epub 2022 Oct 27.
Cancer Res Commun. 2022.
PMID: 36311816
Free PMC article.
Item in Clipboard
Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention.
Ghezelayagh TS, Stewart LE, Norquist BM, Bowen DJ, Yu V, Agnew KJ, Pennington KP, Swisher EM.
Ghezelayagh TS, et al.
Fam Cancer. 2020 Apr;19(2):143-151. doi: 10.1007/s10689-020-00166-5. Epub 2020 Feb 24.
Fam Cancer. 2020.
PMID: 32096072
Item in Clipboard
Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database.
Ghezelayagh T, Rauh-Hain JA, Growdon WB.
Ghezelayagh T, et al.
Obstet Gynecol. 2015 Jun;125(6):1353-1361. doi: 10.1097/AOG.0000000000000861.
Obstet Gynecol. 2015.
PMID: 26000506
Item in Clipboard
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
Ghezelayagh TS, Wu ES, Barber EL, Dao MD, Zsiros E, Urban RR, Gray HJ, Goff BA, Shah CA, Neubauer NL, Dai JY, Tanyi JL, Liao JB.
Ghezelayagh TS, et al.
Eur J Gynaecol Oncol. 2023 Feb;44(1):17-25. doi: 10.22514/ejgo.2023.002. Epub 2023 Feb 14.
Eur J Gynaecol Oncol. 2023.
PMID: 36874058
Free PMC article.
Item in Clipboard
Cite
Cite